MARKUS WROBEL: Open Payments
NPI 1669093928 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 15 payments from 12 companies in 2025. Trend: 2023 $17 · 2024 $111 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| ViiV Healthcare Company | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $44 |
| ABBVIE INC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $20 |
| RGH Enterprises LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: EVENITY, APRETUDE, NURTEC ODT, VRAYLAR, Wegovy, Xelstrym, Cologuard Collection Kit, XIFAXAN.
Industry payments across IL — which companies pay providers there.
